INITIAL SINGLE-STRAND DNA DAMAGE AND CELLULAR PHARMACOKINETICS OF BLEOMYCIN-A2

被引：18

作者：

LAZO, JS

SCHISSELBAUER, JC

MEANDZIJA, B

KENNEDY, KA

机构：

[1] GEORGE WASHINGTON UNIV,SCH MED,WASHINGTON,DC 20037

[2] YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510

来源：

BIOCHEMICAL PHARMACOLOGY | 1989年 / 38卷 / 13期

关键词：

D O I：

10.1016/0006-2952(89)90078-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2207 / 2213

页数：7

共 32 条

[1] BLEOMYCIN-RESISTANT CELLS CONTAIN INCREASED BLEOMYCIN-HYDROLASE ACTIVITIES [J].

AKIYAMA, S ;

IKEZAKI, K ;

KURAMOCHI, H ;

TAKAHASHI, K ;

KUWANO, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (01) :55-60

[2] DNA DAMAGE AND GROWTH-INHIBITION IN CULTURED HUMAN-CELLS BY BLEOMYCIN CONGENERS [J].

BERRY, DE ;

CHANG, LH ;

HECHT, SM .

BIOCHEMISTRY, 1985, 24 (13) :3207-3214

[3] ISOLATION AND CHARACTERIZATION OF BLEOMYCIN-RESISTANT CLONES OF CHO CELLS [J].

BRABBS, S ;

WARR, JR .

GENETICAL RESEARCH, 1979, 34 (03) :269-279

[4]

BURGER RM, 1982, J BIOL CHEM, V257, P3372

[5] COPPER-DEPENDENT CLEAVAGE OF DNA BY BLEOMYCIN [J].

EHRENFELD, GM ;

SHIPLEY, JB ;

HEIMBROOK, DC ;

SUGIYAMA, H ;

LONG, EC ;

VANBOOM, JH ;

VANDERMAREL, GA ;

OPPENHEIMER, NJ ;

HECHT, SM .

BIOCHEMISTRY, 1987, 26 (03) :931-942

[6]

IGBAL ZM, 1976, CANCER RES, V36, P3834

[7]

KENNEDY KA, 1985, CANCER RES, V45, P4071

[8]

LAZO JS, 1985, MOL PHARMACOL, V27, P387

[9]

LAZO JS, 1986, CANCER RES, V46, P2236

[10]

LAZO JS, 1985, CANCER RES, V45, P2103

← 1 2 3 4 →